Skip to main content

NuGen Looks to Build Reputation in New York Market by Partnering with AMDeC

NEW YORK, March 9 (GenomeWeb News) - In an effort to raise its East Coast profile, NuGen will begin providing its Ovation RNA amplification systems to AMDeC Foundation, a consortium of more than 30 New York healthcare organizations, research institutions, and medical schools, the company said this week.


NuGen, which said it hoped its relationship with AMDeC would build the firm's reputation in the New York market, has also agreed to sponsor AMDeC initiatives in the future, and provide members with on-site training programs for its amplification kits.


"Our collaboration will give us greater visibility at many New YorkState medical research institutions and further solidify our reputation as a significant emerging company in the functional genomics market place," said Elizabeth Hutt, vice president of commercial operations at NuGen.


Maria Mitchell, the president of AMDeC, said that NuGen's Ovation kits would be useful in biomedical research conducted by members that include MemorialSloanKetteringCancerCenter and the Weill Medical College of Cornell University.


Financial details of the agreement were not discussed.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.